Trials / Completed
CompletedNCT01982357
Measurement of Neonatal Microvascular Hemodynamics Using Non-invasive Optical Technologies
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 32 (actual)
- Sponsor
- University of California, Irvine · Academic / Other
- Sex
- All
- Age
- 1 Minute – 1 Month
- Healthy volunteers
- Accepted
Summary
Alterations to microvascular blood flow in premature infants, are known to contribute to several major disease entities. The optically-measured tissue blood flow, to determine tissue perfusion that can be use to detect blood loss.
Detailed description
The researchers want to use optical technologies to non-invasively detect blood flow that can tell the onset of blood loss. The research can measure blood flow in stable premature infants in the Neonatal Intensive Care Unit over the duration of several weeks. The technologies are Laser Speckle Imaging and Diffuse Optical Spectroscopy. Laser Speckle Imaging non-contact imaging technology, is sensitive to blood flow in superficial tissues. Diffuse Optical Spectroscopy, a probe-based contact technology like pulse oximetry, measures hemoglobin concentrations and states deeper below the skin surface.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Laser Speckle Imaging and Diffuse Optical Spectroscopy | Laser Speckle Imaging and Diffuse Optical Spectroscopy |
Timeline
- Start date
- 2013-07-17
- Primary completion
- 2015-06-30
- Completion
- 2015-06-30
- First posted
- 2013-11-13
- Last updated
- 2022-11-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01982357. Inclusion in this directory is not an endorsement.